Literature DB >> 24972569

Association between 5-HTTLPR polymorphism and Parkinson's disease: a meta analysis.

Lianbo Gao1, Honghua Gao.   

Abstract

To investigate the genetic association of 5-HTTLPR polymorphism and Parkinson's disease (PD) or depression in PD by using meta analysis. Published association studies on genotype or allele frequencies of the 5-HTTLPR in patients with or without PD or in PD patients with or without depression in all ethnic groups were included. A biallelic meta-analysis, including biallelic frequency model, biallelic dominant model (BDM) and biallelic recessive model, was performed using the Cochrane Review Manager (RevMan, version 5.2) to calculate the pooled odds ratio and its corresponding 95 % CI with a random-effect model. Six studies met the criteria for the meta-analysis of association of 5-HTTLPR and three studies were included for the association of 5-HTTLPR and depression in PD. The meta-analysis results did not show significant association between 5-HTTLPR and PD or depression in PD, except for a moderate negative association between 5-HTTLPR and PD in Asian subgroup (2 studies) using the BDM approach. Our meta-analysis result does not support a direct primary effect of 5-HTTLPR on PD or depression in PD. Further association studies with larger sample sizes preferably taking into consideration factors such as additional allelic variants in the 5-HTTLPR, ethnic variation of the 5-HTTLPR distribution and gene-gene interaction are necessary to reach a more definite conclusion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24972569     DOI: 10.1007/s11033-014-3484-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  45 in total

1.  Allelic variation of a functional promoter polymorphism of the serotonin transporter and depression in Parkinson's disease.

Authors:  Rainald Mössner; Peter Riederer
Journal:  Parkinsonism Relat Disord       Date:  2006-08-28       Impact factor: 4.891

2.  Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.

Authors:  R Mössner; A Henneberg; A Schmitt; Y V Syagailo; M Grässle; T Hennig; R Simantov; M Gerlach; P Riederer; K P Lesch
Journal:  Mol Psychiatry       Date:  2001-05       Impact factor: 15.992

3.  Serotonin transporter gene polymorphism and affective disorder.

Authors:  H Kunugi; M Tatsumi; T Sakai; M Hattori; S Nanko
Journal:  Lancet       Date:  1996-05-11       Impact factor: 79.321

4.  An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk.

Authors:  Xianzhang Hu; Gabor Oroszi; Jeffrey Chun; Tom L Smith; David Goldman; Marc A Schuckit
Journal:  Alcohol Clin Exp Res       Date:  2005-01       Impact factor: 3.455

5.  The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants.

Authors:  M Nakamura; S Ueno; A Sano; H Tanabe
Journal:  Mol Psychiatry       Date:  2000-01       Impact factor: 15.992

6.  The serotonin transporter gene and Parkinson's disease.

Authors:  S J McCann; M E McManus; A G Johnson; G D Mellick; D G Le Couteur; S M Pond
Journal:  Eur Neurol       Date:  2000       Impact factor: 1.710

Review 7.  Serotonin transporter: gene, genetic disorders, and pharmacogenetics.

Authors:  Dennis L Murphy; Alicja Lerner; Gary Rudnick; Klaus-Peter Lesch
Journal:  Mol Interv       Date:  2004-04

Review 8.  Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?

Authors:  Stephen J Kish
Journal:  Adv Neurol       Date:  2003

Review 9.  Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.

Authors:  David J Burn
Journal:  Mov Disord       Date:  2002-05       Impact factor: 10.338

10.  Serotonin transporter gene polymorphic element 5-HTTLPR increases the risk of sporadic Parkinson's disease in Italy.

Authors:  Diego Albani; Angelica Vittori; Sara Batelli; Letizia Polito; Stefania De Mauro; Daniela Galimberti; Elio Scarpini; Carlo Lovati; Claudio Mariani; Gianluigi Forloni
Journal:  Eur Neurol       Date:  2009-06-12       Impact factor: 1.710

View more
  2 in total

Review 1.  Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

Authors:  Jose A Santiago; Virginie Bottero; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2017-12-04       Impact factor: 5.750

Review 2.  The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease.

Authors:  Daniele Caligiore; Flora Giocondo; Massimo Silvetti
Journal:  IBRO Neurosci Rep       Date:  2022-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.